Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Idorsia (0RQE)

Idorsia Ltd
Date:
Sort by:
 Showing the most relevant articles for your search:LSE:0RQE
DateTimeSourceHeadlineSymbolCompany
25/07/202406:00UK RegulatoryIdorsia announces financial results for the first half 2024LSE:0RQEIdorsia Ltd
18/07/202416:45UK RegulatoryInvitation to Idorsia's Half Year 2024 Financial Reporting webcast and conference callLSE:0RQEIdorsia Ltd
01/07/202406:00UK RegulatoryIdorsia’s JERAYGO (aprocitentan) approved in Europe as first and only ERA for the treatment of resistant hypertensionLSE:0RQEIdorsia Ltd
28/06/202416:45UK RegulatoryHigher cantonal composition authority issues written court decision in respect to the amendments to the terms of the 2024 convertible bondsLSE:0RQEIdorsia Ltd
25/06/202416:45UK RegulatoryHigher cantonal composition authority approved the amendments to the terms of the 2024 convertible bondsLSE:0RQEIdorsia Ltd
21/06/202406:00UK RegulatoryIdorsia’s novel treatment for chronic insomnia wins the prestigious Prix Galien Suisse 2024 innovation award in the ‘Primary & Speciality’ categoryLSE:0RQEIdorsia Ltd
13/06/202410:00UK RegulatoryIdorsia holds its Annual General Meeting of ShareholdersLSE:0RQEIdorsia Ltd
03/06/202406:00UK RegulatoryNew data with daridorexant to be presented at SLEEP 2024LSE:0RQEIdorsia Ltd
03/06/202406:00UK RegulatoryNew data with daridorexant to be presented at SLEEP 2024LSE:0RQEIdorsia Ltd
31/05/202406:00UK RegulatoryData from the PRECISION study of aprocitentan to be presented at the European Society of Hypertension Annual Meeting 2024LSE:0RQEIdorsia Ltd
31/05/202406:00UK RegulatoryData from the PRECISION study of aprocitentan to be presented at the European Society of Hypertension Annual Meeting 2024LSE:0RQEIdorsia Ltd
23/05/202406:00UK RegulatoryIdorsia issues invitation to the 2024 Annual General Meeting of ShareholdersLSE:0RQEIdorsia Ltd
23/05/202406:00UK RegulatoryIdorsia issues invitation to the 2024 Annual General Meeting of ShareholdersLSE:0RQEIdorsia Ltd
21/05/202406:00UK RegulatoryIdorsia announces changes to Idorsia Executive Committee and Board of DirectorsLSE:0RQEIdorsia Ltd
21/05/202406:00UK RegulatoryIdorsia announces changes to Idorsia Executive Committee and Board of DirectorsLSE:0RQEIdorsia Ltd
21/05/202405:50UK RegulatoryIdorsia announces financial results for the first quarter 2024 – advancing the company with renewed vigorLSE:0RQEIdorsia Ltd
21/05/202405:50UK RegulatoryIdorsia announces financial results for the first quarter 2024 – advancing the company with renewed vigorLSE:0RQEIdorsia Ltd
21/05/202405:40UK RegulatoryIdorsia announces financial results for the full year of 2023 – Adapting the company to create sustainable valueLSE:0RQEIdorsia Ltd
21/05/202405:40UK RegulatoryIdorsia announces financial results for the full year of 2023 – Adapting the company to create sustainable valueLSE:0RQEIdorsia Ltd
14/05/202416:45UK RegulatoryInvitation to Idorsia's Full Year 2023 and Q1 2024 Financial Reporting webcast and conference callLSE:0RQEIdorsia Ltd
14/05/202416:45UK RegulatoryInvitation to Idorsia's Full Year 2023 and Q1 2024 Financial Reporting webcast and conference callLSE:0RQEIdorsia Ltd
06/05/202417:35UK RegulatoryBondholders approve amended terms of the 2024 convertible bondsLSE:0RQEIdorsia Ltd
06/05/202417:35UK RegulatoryBondholders approve amended terms of the 2024 convertible bondsLSE:0RQEIdorsia Ltd
01/05/202417:00UK RegulatoryIdorsia increases the consent fee in connection with the proposed restructuring of the 2024 convertible bondLSE:0RQEIdorsia Ltd
01/05/202417:00UK RegulatoryIdorsia increases the consent fee in connection with the proposed restructuring of the 2024 convertible bondLSE:0RQEIdorsia Ltd
26/04/202406:00UK RegulatoryJERAYGO (aprocitentan) recommended for approval in Europe for the treatment of resistant hypertensionLSE:0RQEIdorsia Ltd
26/04/202406:00UK RegulatoryJERAYGO (aprocitentan) recommended for approval in Europe for the treatment of resistant hypertensionLSE:0RQEIdorsia Ltd
23/04/202406:00UK RegulatoryIdorsia publishes an invitation to a bondholder meetingLSE:0RQEIdorsia Ltd
23/04/202406:00UK RegulatoryIdorsia publishes an invitation to a bondholder meetingLSE:0RQEIdorsia Ltd
17/04/202406:00UK RegulatoryIdorsia publishes a Financial Status required for an upcoming bondholder meetingLSE:0RQEIdorsia Ltd
 Showing the most relevant articles for your search:LSE:0RQE